BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8259853)

  • 1. [Antiemetic efficacy of granisetron in pediatric cancer treatment--(2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis].
    Hirota T; Honjo T; Kuroda R; Saeki K; Katano N; Sakakibara Y; Shimizu H; Fujimoto T
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2369-73. PubMed ID: 8259853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer chemotherapy].
    Hisano C; Nakano S; Okuma K; Masumoto N; Fujishima H; Nakamura M; Niho Y
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1175-81. PubMed ID: 8751806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative trial of granisetron versus granisetron plus methylprednisolone for the prevention of nausea and vomiting induced by cancer chemotherapy].
    Hirota T; Shimizu H; Fujimoto T; Koike A; Kojima T; Noguchi M; Yabushita H; Kato R; Daimaru O; Noda A
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):91-6. PubMed ID: 8291920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S; Akman SA; Ozgenç F; Kansoy S
    Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Study Group].
    Uchida K; Akaza H; Shimazui T; Kikuchi K; Manabe F; Iwasaki A; Ishikawa S; Noguchi R; Otani M; Hattori K; Kondo F; Nishijima Y; Sato K; Koiso K; Hinotsu S
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):81-6. PubMed ID: 8546475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
    Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg].
    Hirota T; Honjo T; Kuroda R; Saeki K; Katano N; Sakakibara Y; Shimizu H; Fujimoto T
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2201-5. PubMed ID: 8251030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Granisetron versus granisetron plus methylprednisolone in the prevention of chemotherapy induced nausea and vomiting--in adjuvant chemotherapy, including CDDP against gastric cancer].
    Kurita A; Takashima S; Nakata M; Kubo Y; Saiki T; Ohsumi S; Yokoyama N; Tanada M; Takiyama W; Saeki H
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):49-54. PubMed ID: 9020945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Nara Medical University Kytril Study Group].
    Ozono S; Okajima E; Hirao YK; Natsume O; Kaneko Y; Ohara S; Tabata S; Watanabe S; Aoyama H; Sasaki K; Matsuki H; Takashima K; Maruyama Y; Yoshikawa M; Yamada K; Momose H; Hiramatsu T; Hayashi Y; Babaya K; Shiomi T
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):349-56. PubMed ID: 9051139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prevention of cancer chemotherapy-induced emesis with granisetron and clonazepam].
    Eguchi F; Shindo M; Emoto M; Mohtai H; Hachisuga T; Kawarabayashi T; Shirakawa K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):233-7. PubMed ID: 7857098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for the prophylactic treatment of emesis induced by cisplatin-containing chemotherapy].
    Tsukuda M; Kokatsu T; Furukawa S; Kohno H; Kubota A; Furukawa M; Enomoto H
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2037-41. PubMed ID: 8215478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does increasing the steroid dose enhance the efficacy of the antiemetic combination of granisetron and methylprednisolone in gynecologic cancer patients--a randomized study.
    Lehoczky O; Udvary J; Bagaméri A; Pulay T
    Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):94-7. PubMed ID: 15036719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
    Tanaka K; Sekine M; Serikawa T; Sanada H; Shichiri K; Fujimori R
    Gan To Kagaku Ryoho; 1998 May; 25(6):907-13. PubMed ID: 9617330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
    Mabro M; Granisétron PK
    Bull Cancer; 1999 Mar; 86(3):295-301. PubMed ID: 10210764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Granisetron, a new and potent antiemetic for treatment of cytostatic drug-induced vomiting in gynecological malignancies].
    Regidor PA; Schindler AE
    Geburtshilfe Frauenheilkd; 1994 Jan; 54(1):51-4. PubMed ID: 8150251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
    Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of granisetron as an inhibitor of nausea and vomiting induced by oral anticancer drugs.
    Togo S; Akiyama H; Yamaguchi S; Ichikawa Y; Ike H; Shimada H
    Oncol Rep; 2002; 9(2):277-82. PubMed ID: 11836592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.